August 22, 2018 Bio/Pharma/CRO Product Launch

RAPID IDENTIFICATION OF REDOX CYCLING COMPOUNDS – REDOXprofiler™

Dundee, UK – 22nd August 2018: Ubiquigent Limited, a company specializing in providing ubiquitin cell-signalling system drug discovery services, research tools and novel targeted chemistry, announced today that it has launched REDOXprofiler™. The new service, validated following a collaboration with Medivir AB, enables the rapid identification of REDOX cycling compounds (RCCs), which may generate false... Read more

August 15, 2018 Bio/Pharma/CRO PR/Corporate

Ubiquigent Awarded Innovate UK Grant, Closes Further Round of Investment and Strengthens Management Team

Dundee, UK, 15th August 2018: Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system targeted drug discovery, announced today that it was awarded a new grant from Innovate UK as part of its Investor Accelerator Pilot to support a project entitled; ‘The development of novel compounds to seed a neurodegeneration drug discovery programme’.... Read more